Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct;19(10):625-626.
doi: 10.1038/s41581-023-00748-3.

GFR slope as a surrogate marker for future kidney failure

Jennifer S Lees  1   2 , Patrick B Mark  3   4
Affiliations
Comment

GFR slope as a surrogate marker for future kidney failure

Jennifer S Lees et al. Nat Rev Nephrol. 2023 Oct.
No abstract available

PubMed Disclaimer

Comment on

  • A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.
    Inker LA, Collier W, Greene T, Miao S, Chaudhari J, Appel GB, Badve SV, Caravaca-Fontán F, Del Vecchio L, Floege J, Goicoechea M, Haaland B, Herrington WG, Imai E, Jafar TH, Lewis JB, Li PKT, Maes BD, Neuen BL, Perrone RD, Remuzzi G, Schena FP, Wanner C, Wetzels JFM, Woodward M, Heerspink HJL; CKD-EPI Clinical Trials Consortium. Inker LA, et al. Nat Med. 2023 Jul;29(7):1867-1876. doi: 10.1038/s41591-023-02418-0. Epub 2023 Jun 17. Nat Med. 2023. PMID: 37330614

References

    1. Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392, 2052–2090 (2018). - DOI - PubMed - PMC
    1. Inker, L. A. et al. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure. Nat. Med. https://doi.org/10.1038/s41591-023-02418-0 (2023). - DOI - PubMed
    1. Yu, T. et al. Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey. BMJ Open 5, e007960 (2015). - DOI - PubMed - PMC
    1. Inker, L. A. et al. GFR slope as a surrogate end point for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomized controlled trials. J. Am. Soc. Nephrol. 30, 1735–1745 (2019). - DOI - PubMed - PMC
    1. Keith, D. S., Nichols, G. A., Gullion, C. M., Brown, J. B. & Smith, D. H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med. 164, 659–663 (2004). - DOI - PubMed

LinkOut - more resources